¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"membranous bone growth"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • growth delay
    ¼ºÀåÁö¿¬
  • growth factor
    ¼ºÀåÀÎÀÚ
  • growth failure
    ¹ßÀ°ºÎÀü, ¼ºÀåºÎÀü
  • growth fraction
    ¼ºÀåºÐÀ²
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth hormone-inhibiting hormone
    ¼ºÀåÈ£¸£¸ó¾ïÁ¦È£¸£¸ó
  • growth hormone-releasing hormone
    ¼ºÀåÈ£¸£¸ó¹æÃâÈ£¸£¸ó
  • growth inducer
    ¼ºÀåÀ¯¹ßÀÎÀÚ
  • growth line
    ¼ºÀå¼±
  • growth pattern
    ¼ºÀå¾ç½Ä
  • growth period
    ¼ºÀå±â°£
  • growth phase
    Áõ½Ä±â
  • growth plate
    ¼ºÀåÆÇ
  • growth quotient
    ¼ºÀåÁö¼ö, ¹ßÀ°Áö¼ö
  • growth rate
    ¼ºÀå·ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶
  • facial bone contouring surgery
    ¾ó±¼»ÀÀ±°û±³Á¤¼ú
  • bone marrow transplantation
    °ñ¼öÀ̽Ä(¼ú)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • exponential growth
    Áö¼öÁõ½Ä
  • exponential growth rate
    ´ë¼öÁõ½Ä·ü, Áö¼öÁõ½Ä·ü
  • fetal growth retardation
    žƼºÀåÁö¿¬
  • fibroblast growth factor
    ¼¶À¯¸ð¼¼Æ÷¼ºÀåÀÎÀÚ
  • growth factor
    ¼ºÀåÀÎÀÚ
  • growth fraction
    ¼ºÀåºÐÀ²
  • hematopoietic growth factor
    Ç÷¾×Çü¼º¼ºÀåÀÎÀÚ, Á¶Ç÷¼ºÀåÀÎÀÚ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • macrophage-derived growth factor
    Å«Æ÷½Ä¼¼Æ÷À¯·¡¼ºÀåÀÎÀÚ
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • growth
    ¼ºÀå, Áõ½Ä
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • iliac bone <³ª> os ilium
    Àå°ñ(Àå°ñ).
  • iliac bone ³ª os ilium
    Àå°ñ(íóÍé).
  • immature compact bone
    ¹Ì¼º¼÷Ä¡¹Ð»À
  • incisive bone
    (¾Õ´Ï»À)
  • incisive bone premaxilla ; os incisivum ³ª
    ¾Õ´Ï°ñ, ÀýÄ¡°ñ(ôîöÍÍé).
  • inferior body of hyoid bone
    ¸ñ»Ô»À¾Æ·¡¸öÅë
  • inlay bone graft
    ³»Àç °ñ À̽Ä(Ò®î¤Íéì¹ãÕ), °¨ÀÔ °ñ À̽Ä(ÊîìýÍéì¹ãÕ).
  • innominate bone ³ª os coxae
    °ü°ñ.
  • innominate bone ³ª os coxae
    ¹«¸í°ñ(ÙíÙ£Íé), µÐ°ñ(ÔëÍé), °ñ¹Ý°ñ(ÍéÚïÍé), ¾ûÄ¡ »À, °ü°ñ.
  • petrosal cartilage of temporal bone
    °üÀÚ»À¹ÙÀ§¿¬°ñ
  • petrous bone
    Ãßü°ñ
  • pisiform bone
    µÎ»ó°ñ(ÔéßÒÍé).
  • pisiform bone
    Äá¾Ë»À
  • pisiform bone
    µÎ»ó°ñ(ÔéßÒÍé).
  • plane bone ³ª os planum
    ÆíÆò°ñ(ø·øÁÍé).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • membranous inflammation
    ¸·¼º¿°Áõ(¡­àõæúñø)
  • membranous interventricular septum
    ½É½ÇÁ߰ݸ·ºÎºÐ, ¸·ºÎºÐ½É½ÇÁß°Ý, ¸·¼º ½É?
  • membranous interventricular septum ; pars membranacea septi interventricularis
    ½É½ÇÁ߰ݸ·ºÎºÐ, ¸·ºÎºÐ½É½ÇÁß°Ý, ¸·¼º ½É½ÇÁß°Ý.
  • membranous labyrinth
    ¸·¹Ì·Î(Ø¯Ú»ÖØ).
  • membranous labyrinth
    ¸·¹Ì·Î
  • membranous labyrinth
    ¸·¹Ì·Î
  • membranous lamina
    ¸·¼ºÆÇ
  • membranous laryngitis
    ¸·¼ºÈĵο°(¡­ýªÔéæú).
  • membranous laryngitis
    ¸·(¼º)Èĵο°
  • membranous nephropathy
    ¸·¼º½Åº´Áõ(¡­ãìÜ»ñø)
  • membranous ossification
    ¸·¼º°ñÈ­(دàõÍéûù).
  • membranous ossification
    ¸·»À¹ß»ý
  • membranous part
    ¸·ºÎºÐ, ¸·¼ººÎ(دàõÝ»).
  • membranous part
    ¸·ºÎºÐ
  • membranous part of interventricular septum
    ½É½ÇÁß°ÝÀÇ ¸·ºÎºÐ, ¸·¼º½É½ÇÁß°Ý(¡­ãýãøñé
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Lacrimal bone
    ´«¹°»À [´©°ñ]
    [¿¾ ¿ë¾î] ´©°ñ
  • Tuberosity of fifth metatarsal bone
    ´Ù¼¸Â°¹ßÇ㸮»À°ÅÄ£¸é
    [¿¾ ¿ë¾î] Á¦5ÁßÁ·(ô)°ñÁ¶¸é
  • Occipital bone
    µÚÅë¼ö»À [Èĵΰñ]
    [¿¾ ¿ë¾î] Èĵΰñ
  • Squama of occipital bone
    µÚÅë¼ö»Àºñ´Ã
    [¿¾ ¿ë¾î] Èĵθ°
  • Parietal bone
    ¸¶·ç»À [µÎÁ¤°ñ]
    [¿¾ ¿ë¾î] µÎÁ¤°ñ
  • Lesser horn of hyoid bone
    ¸ñ»Ô»ÀÀÛÀº»Ô
    [¿¾ ¿ë¾î] ¼³°ñ¼Ò°¢
  • Greater horn of hyoid bone
    ¸ñ»Ô»ÀÅ«»Ô
    [¿¾ ¿ë¾î] ¼³°ñ´ë°¢
  • Immature compact bone
    ¹Ì¼º¼÷Ä¡¹Ð»À
    [¿¾ ¿ë¾î] ÀüÄ¡¹Ð°ñ
  • Lunate bone
    ¹Ý´Þ»À
    [¿¾ ¿ë¾î] ¿ù»ó°ñ
  • Articular surface for navicular bone
    ¹ß¹è°üÀý¸é
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ°üÀý¸é
  • Navicular bone
    ¹ß¹è»À
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ
  • Tuberosity of navicular bone
    ¹ß¹è»À°ÅÄ£¸é
    [¿¾ ¿ë¾î] ÁÖ»ó°ñÁ¶¸é
  • Head of metatarsal bone
    ¹ßÇ㸮»À¸Ó¸®
    [¿¾ ¿ë¾î] ÁßÁ·(ô)°ñµÎ
  • Body of metatarsal bone
    ¹ßÇ㸮»À¸öÅë
    [¿¾ ¿ë¾î] ÁßÁ·(ô)°ñü
  • Base of metatarsal bone
    ¹ßÇ㸮»À¹Ù´Ú
    [¿¾ ¿ë¾î] ÁßÁ·(ô)°ñÀú
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • metacarpal bone
    Áß¼ö°ñ
  • metatarsal bone
    ÁßÁ·°ñ
  • navicular bone
    ¹ß¹è°ñ, ÁÖ»ó°ñ
  • new bone formation
    ½Å°ñÇü¼º
  • occipital bone
    逵롖
  • palatine bone
    ±¸°³°ñ
  • parietal bone
    µÎÁ¤°ñ
  • periosteal bone
    °ñ¸·(¼º)°ñ
  • periosteal new bone
    °ñ¸·¼º½Å»ý°ñ
  • pubic bone
    Ä¡°ñ
  • reactive bone excrescence
    ¹ÝÀÀ¼º°ñµ¹Ãâ
  • resorption of bone
    °ñÈí¼ö
  • scaphoid bone
    ¼Õ¹è°ñ, ÁÖ»ó°ñ
  • sclerotic bone island
    °æÈ­¼º°ñ¼¶
  • sesamoid bone
    Á¾ÀÚ°ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MG Marcus Gunn [pupil]; margin; medial gastrocnemius [muscle]; membranous glomerulonephritis; menopausa...
MGN medial geniculate nucleus; membranous glomerulonephritis
MGP marginal granulocyte pool; marginating granulocyte pool; membranous glomerulonephropathy; mucin glyc...
MLN manifest latent nystagmus; membranous lupus nephropathy; mesenteric lymph node; motilin
MOIVC membranous obstruction of the inferior vena cava
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ABMT Allogeneic bone marrow transplantation
ABL Alveolar bone loss
ABC Aneurysmal bone cyst
ABMD Areal bone mineral density
ABMT Autologous Bone Marrow Transplant
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • alveolar bone graft
    Ä¡Á¶°ñ À̽Ä, Ä¡Á¶°ñ À̽ļú
  • aneurismal bone cyst
    µ¿¸Æ·ù¼º °ñ ³¶Á¾
    ±¸°­ÀÇ °Å´ë ¼¼Æ÷ º´¼Ò·Î, °ñ Ç÷Á¾ÀÇ Ä¡À¯ °úÁ¤¿¡¼­ »ý±ä´Ù.
  • aneurysmal bone cyst
    µ¿¸Æ·ù¼º °ñ³¶
  • ankle bone
    ¹ß¸ñ »À
  • autogenous bone
    ÀÚ°¡ °ñ
  • base of metacarpal bone
    ¼ÕÇ㸮»À ¹Ù´Ú
  • blade bone
    °ß°© °ñ
  • body of hyoid bone
    ¼³°ñ ü
  • body shaft of metacarpal bone
    Á¤¿Ü Áß¼ö°ñü
    µ¿ÀǾî=cor
  • bone
    °ñ, »À
    1. ´ë´Ù¼ö ôÃß µ¿¹°ÀÇ °ñ°ÝÀÇ ´ëºÎºÐÀ» ±¸¼ºÇÏ´Â °ß°íÇÑ ÇüÅÂÀÇ °áÇÕÁ¶Á÷À̸ç, À¯±â ¼ººÐ°ú ¹«±â ¼ººÐÀ¸·Î ±¸¼ºµÈ´Ù. ±âÁúÀº ±³¿øÁú ¼¶À¯ ±¸Á¶¸¦ °¡Áö¸ç ±× ¼Ó¿¡ ¹«±â ¼ººÐÀÌ Ä§ÅõµÇ¾î ÀÖ´Ù. ¹«±â ¼ººÐÀº ÁÖ·Î Àλê Ä®½·°ú ź»ê Ä®½·À¸·Î µÇ¾î ÀÖ°í, À̰͵éÀÌ °ñÀÇ °æµµ¿¡ ±â¿©Çϰí ÀÖ´Ù. 2. ÁÖ¿ä ¼ººÐÀº °ñÁú·Î °ñÁ¶Á÷À¸·Î µÇ¾îÀÖÀ¸¸ç ¿ÜÃøÀº °ñ¸·À¸·Î µ¤¿©ÀÖ°í ³»ºÎ¿¡´Â °ñ¼ö°¡ È帥´Ù. ¿ÜÇüÀ¸·Î Àå°ñ, ´Ü°ñ, ÆíÆò°ñ·Î ³ª´µ¾îÁø´Ù.
  • bone activity
    °ñ Ȱ¼º
  • bone age
    °ñ·É, °ñ ¿¬·É
    °ñ ¼º¼÷µµ¸¦ ³ªÅ¸³»´Â °³³äÀÌ°í °Ç°­¿¡¼­ ¾òÀº ÀÏÁ¤ÇÑ Ç¥ÁØÀ» ¿¬·É°úÀÇ °ü°è·Î Ç¥ÇöÇÑ °ÍÀÌ´Ù.
  • bone and joint surgery
    °ñ°üÀý ¿Ü°ú
  • bone ash
    °ñȸ
    »À¸¦ Å¿ö¼­ ¸¸µç °¡·ç, ºñ·á¿¡ ¾²À̱⵵ ÇÑ´Ù.
  • bone augmentation
    °ñ Áõ´ë¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
receptors, nerve growth factor Cell surface receptors that bind nerve growth factor (ngf) and trigger intracellular changes influencing the behaviour of cells. Nerve growth factor receptors mediate the effects of nerve growth factor on the survival and growth of neurons.
(12 Dec 1998)
receptors, platelet-derived growth factor Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain.
(12 Dec 1998)
receptors, transforming growth factor beta Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behaviour of cells. Two types of transforming growth factor receptors have been recognised. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see receptors, epidermal growth factor-urogastrone).
(12 Dec 1998)
vertical growth phase Spread of melanoma cells from the epidermis into the dermis and later the subcutis, from which site metastasis may take place.
(05 Mar 2000)
cell growth <cell biology> Usually used to mean increase in the size of a population of cells though strictly should be reserved for an increase in cytoplasmic volume of an individual cell.
(26 Mar 1998)
melanoma growth stimulatory activity Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils.
(18 Nov 1997)
personal growth laboratory A sensitivity training setting in which the primary emphasis is on each participant's potentialities for creativity, empathy, and leadership.
See: sensitivity training group.
(05 Mar 2000)
growth 1. The process of growing; the gradual increase of an animal or a vegetable body; the development from a seed, germ, or root, to full size or maturity; increase in size, number, frequency, strength, etc.; augmentation; advancement; production; prevalence or influence; as, the growth of trade; the growth of power; the growth of intemperance. Idle weeds are fast in growth.
2. That which has grown or is growing; anything produced; product; consequence; effect; result. "Nature multiplies her fertile growth." (Milton)
Origin: Icel. Gror, gri. See Grow.
Source: Websters Dictionary
(01 Mar 1998)
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
growth arrest lines Dense lines parallel to the growth plates of long bones on radiographs, representing temporary slowing or cessation of longitudinal growth.
Synonym: Harris' lines.
(05 Mar 2000)
growth associated proteins <growth factor> Group of developmentally regulated polypeptides thought to be critical for the formation of neural circuitry. The acidic membrane phosphoprotein GAP 43 is synthesised and transported down regenerating and developing axons, pp46 localised in growth cone membranes during embryogenesis, B 50 in mature presynaptic membranes in the regulation of phosphotidylinositol turnover and F1 in the hippocampus during long-term potentiation, are now all known to be the same protein.
(18 Nov 1997)
growth cone <cell biology> A specialised region at the tip of a growing neurite that is responsible for sensing the local environment and moving toward the neuron's target cell. Growth cones are hand shaped, with several long filopodia that differentially adhere to surfaces in the embryo. Growth cones can be sensitive to several guidance cues, for example: surface adhesiveness, growth factors, neurotransmitters and electric fields (galvanotropism).
(18 Nov 1997)
growth cone collapse <cell biology> Loss of motile activity and cessation of advance by growth cones. There are now thought to be specific molecules that inhibit the motility of particular growth cones and are important in establishing correct pathways in developing nervous systems.
See: axon pathfinding.
(18 Nov 1997)
growth control <cell biology> When applied to cells usually means control of growth of the population, i.e. Of the rate of division rather than of the size of an individual cell.
(18 Nov 1997)
growth curve A graphic representation of the change in size of an individual or a population over a period of time.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á